Example: Heart Attack

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Total 9779 results

NCT02814487

Completed

MSFC Versus DAM. A Smartphone Application for Multiple Sclerosis Self-assessment. (DAM)

Multiple Sclerosis
NCT02317263

Withdrawn

A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis

Multiple Sclerosis
NCT02081508

Completed

Consolidation & Interference in Multiple Sclerosis

Multiple Sclerosis
NCT00751881

Completed

An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis (TOWER)

Multiple Sclerosis
NCT02493166

Completed

Dual Task Cost in the Upper Limb in Persons With Multiple Sclerosis (DTC)

Multiple Sclerosis
NCT02339688

Completed

Psychometric Properties Mobility Measures MS (MCS-III-MOB)

Multiple Sclerosis
NCT02664324

Completed

MSPT Device Usability Study (MSPT)

Multiple Sclerosis
NCT01947582

Completed

The Effects of Ankle Foot Orthoses (AFOs) on Mobility in Persons With Multiple Sclerosis (MS)

Multiple Sclerosis
NCT01881191

Completed

Th Effects of Aubagio on Brain Pathology in Multiple Sclerosis Studied Over 12 Months (GZA)

Multiple Sclerosis
NCT01428505

Terminated

[18F]PBR111 and Microglial Activation in Multiple Sclerosis

Multiple Sclerosis
NCT02457091

Completed

Project Get Fit With MS: Guidelines for Exercise Training and Fitness Outcomes in MS (GetFit)

Multiple Sclerosis
NCT02580435

Unknown

Deciphering the Role of the Gut Microbiota in Multiple Sclerosis

Multiple Sclerosis
NCT00370071

Completed

Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis

Multiple Sclerosis
NCT02442570

Completed

A Study to Evaluate Safety and Efficacy of DC-TAB in Multiple Sclerosis

Multiple Sclerosis
NCT00638196

Terminated

Placebo vs. Linoleic Acid Controlled Assessment of Treatment Efficacy in MS (PLACATE-MS)

Multiple Sclerosis
NCT01380041

Terminated

Cytokine in Cerebrospinal Fluid (CSF) From Multiple Sclerosis Patients (CYTOSEP)

Multiple Sclerosis
NCT02390336

Completed

Mobilization With Movement in Patients With Osteoarthritis of the Hip (MWM)

Pathologic Processes | Musculoskeletal Diseases | Joint Disease | Osteoarthritis Hip
NCT02408367

Unknown

Intensity Depended Impacts on Cognitive Functions in Persons With Multiple Sclerosis - a Pilot Study

Multiple Sclerosis
NCT02390830

Completed

Falls Prevention and Balance Rehabilitation in Multiple Sclerosis

Multiple Sclerosis
NCT01863888

Completed

Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis (TERI-DYNAMIC)

Multiple Sclerosis
NCT01454791

Completed

Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients Taking Glatiramer Acetate

Multiple Sclerosis
NCT02365259

Unknown

Phototherapy in Persons With Multiple Sclerosis

Multiple Sclerosis
NCT00744679

Completed

A Pharmacokinetic (PK) Study of Natalizumab (Tysabri) at Steady State

Multiple Sclerosis
NCT01764737

Completed

Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS

Multiple Sclerosis
NCT02346279

Completed

Responsiveness and Minimal Clinical Important Difference of the Multiple Sclerosis Questionnaire for Physiotherapists

Multiple Sclerosis
NCT01836055

Terminated

Imaging Multiple Sclerosis Lesions Using Magnevist and Gadavist

Multiple Sclerosis
NCT01829776

Completed

Pilot Study of Free From Falls Program in Multiple Sclerosis (FFF)

Multiple Sclerosis
NCT01440101

Completed

Natalizumab (BG00002, Tysabri) Study in Japanese Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) (Tysabri Japan)

Multiple Sclerosis
NCT02264704

Unknown

Exercise Intensity and Immune Function in Multiple Sclerosis

Multiple Sclerosis
NCT01883661

Unknown

Safety and Efficacy of BMMNC in Multiple Sclerosis (MS)

Multiple Sclerosis
NCT01034644

Completed

Pharmacogenetic Trial and Long-term Follow-up of the PRISMS Trial (PRISMS-15) (PRISMS-15)

Multiple Sclerosis
NCT01235221

Completed

Open Label Extension Study to Evaluate the Safety and Tolerability of Oral Fampridine-Sustained Release (SR) in Canadian Participants With Multiple Sclerosis Who Participated in Acorda Extension Trials.

Multiple Sclerosis
NCT00873340

Completed

Physical Disability in Patients Treated With Betaferon

Multiple Sclerosis
NCT00828204

Completed

Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects

Multiple Sclerosis
NCT01464749

Completed

Task-oriented Circuit Class Training in Multiple Sclerosis Subjects

Multiple Sclerosis
NCT01414725

Completed

Core Stability Training in Multiple Sclerosis

Multiple Sclerosis
NCT00404352

Completed

REbif FLEXible Dosing in Early Multiple Sclerosis (MS) (REFLEX)

Multiple Sclerosis
NCT00185211

Completed

BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment) and BENEFIT Follow-up Study

Multiple Sclerosis
NCT01846234

Completed

Sodium Intake in Multiple Sclerosis (SALT)

Multiple Sclerosis
NCT00981084

Completed

Impact of Armodafinil on Neurocognition and Cognitive Fatigue in Multiple Sclerosis (MS)

Multiple Sclerosis
NCT01366040

Completed

Avonex PEN Satisfaction and Patients Experience Clinical Trial (ASPECT)

Multiple Sclerosis
NCT00670449

Completed

An Extension Study of the Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing Multiple Sclerosis

Multiple Sclerosis
NCT00139789

Completed

A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple Sclerosis

Multiple Sclerosis
NCT01749943

Completed

Validation of Hand Held Dynamometer for Assessment of Lower Limb Muscle Strength in Multiple Sclerosis (HHD)

Multiple Sclerosis
NCT01626248

Completed

Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control

Multiple Sclerosis
NCT01805986

Unknown

Investigation of GM Pathology Using Ultra High Field (7T) MRI Scanner

Multiple Sclerosis
NCT00510523

Completed

Whole Body Vibration Therapy in Participants With MS Related Balance Deficits

Multiple Sclerosis
NCT00223301

Completed

Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis

Multiple Sclerosis
NCT00086671

Completed

Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS)

Multiple Sclerosis
NCT00811395

Completed

Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis

Multiple Sclerosis

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations